| Over a month ago | ||||
China Transportation… China Transportation Analysts, along with Max Hou, Investor Relations Manager of China Eastern Airlines, discuss the 2012 air travel demand recovery outlook on an Analyst/Industry conference call to be held on February 25 at 9 pm. | ||||
China Transportation… China Transportation Analysts, along with Max Hou, Investor Relations Manager of China Eastern Airlines, discuss the 2012 air travel demand recovery outlook on an Analyst/Industry conference call to be held on February 25 at 9 pm. | ||||
China Transportation… China Transportation Analysts, along with Max Hou, Investor Relations Manager of China Eastern Airlines, discuss the 2012 air travel demand recovery outlook on an Analyst/Industry conference call to be held on February 25 at 9 pm. | ||||
| Over a quarter ago | ||||
Daiwa analyst Kelvin Lau… Daiwa analyst Kelvin Lau downgraded China Eastern Airlines to Outperform from Buy. | ||||
Bernstein analyst Cherry… Bernstein analyst Cherry Leung upgraded China Eastern Airlines to Outperform from Market Perform with a $31.63 price target. Entering 2021, adoption of vaccines will enable passengers to get back to their normal travel routines, Leung tells investors in a research note. The analyst believes the Chinese airline industry "is now back in a positive cycle." | ||||
Morgan Stanley analyst… Morgan Stanley analyst Qianlei Fan upgraded China Eastern Airlines to Overweight from Equal Weight with a price target of $4.19, up from $2.97. Fan upgraded the H-shares of all of the "Big 3" Chinese airlines on the view that quarterly losses may not surpass Q2 levels and that the worst is likely already in the price. The development of a COVID-19 vaccine may trigger market sentiment improvement and Fan expects the market to price in a post-COVID 19 recovery, the analyst added. | |
Catch up on today's… Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sage Therapeutics (SAGE) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Matthew Harrison saying while he believes there remains "a clear place in the treatment paradigm for zuranolone," he also believes a path to filing is currently reflected in the stock price and thinks the overall benefit may be modest when data is reported in the first quarter of 2021. 2. Aurora Cannabis (ACB) and Tilray (TLRY) downgraded to Underperform from Hold at Jefferies. 3. Welltower (WELL) downgraded to Equal Weight from Overweight at Wells Fargo with analyst Todd Stender saying he is increasingly cautious on how Welltower fundamentals can fare during another wave of COVID-19 as case counts rise across the U.S. 4. Urovant Sciences (UROV) downgraded to Neutral from Overweight at JPMorgan with analyst Raghuram Selvaraju saying the company's takeover deal by Sumitovant "appears fully valued." 5. China Eastern Airlines (CEA) downgraded to Neutral from Buy at Goldman Sachs with analyst Ben Hartwright saying China's domestic traffic recovery has been priced in, while yields are a risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. | |
Goldman Sachs analyst Ben… Goldman Sachs analyst Ben Hartwright downgraded China Eastern Airlines to Neutral from Buy with a HK$3.80 price target. China's domestic traffic recovery has been priced in, while yields are a risk, said Hartwright, who is shifting his preference toward Japanese airlines. | |
JPMorgan analyst Karen Li… JPMorgan analyst Karen Li initiated coverage of China Eastern Airlines with an Overweight rating and Rmb 6.40 price target. | |
China Eastern Airlines is… China Eastern Airlines is down -4.6%, or -$1.10 to $22.90. |